Promacta/Revolade eltrombopag regulatory update

GlaxoSmithKline submitted an sNDA to FDA and a variation to an MAA to EMA for Promacta/Revolade eltrombopag to treat thrombocytopenia in adults with chronic HCV infection. The small molecule thrombop...